최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.33 no.6, 2023년, pp.512 - 522
전병균 (경상대학교 사범대학 생물교육학과) , 이성호 (경상대학교 생명과학부)
Cancer with unlimited cell growth is a leading cause of death globally. Various cancer treatments, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy, can be applied alone or in combination depending on the cancer type and stage. New treatments with fewer side ef...
Abbott, M. and Ustoyev, Y. 2019. Cancer and the Immune System: The History and Background of Immunotherapy. Semin. Oncol. Nurs. 35, 150923.?
Ali, A. T., Hochfeld, W. E., Myburgh, R. and Pepper, M. S. 2013. Adipocyte and adipogenesis. Eur. J. Cell. Biol. 92, 229-236.?
Almalki, S. G. and Agrawal, D. K. 2016. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation 92, 41-51.?
Ancey, P. B., Contat, C. and Meylan, E. 2018. Glucose transporters in cancer from tumor cells to the tumor microenvironment. FEBS. J. 285, 2926-2943.?
Arafa, K. K., Ibrahim, A., Mergawy, R., El-Sherbiny, I. M., Febbraio, F. and Hassan, R. Y. A. 2022. Advances in cancer diagnosis: bio-electrochemical and biophysical characterizations of cancer cells. Micromachines (Basel) 26, 1401.?
Artwohl, M., Holzenbein, T., Furnsinn, C., Freudenthaler, A., Huttary, N., Waldhausl, W. K. and Baumgartner-Parzer, S. M. 2005. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells. Thromb. Haemost. 93, 810-815.?
Baker, J., Ajani, J., Scotte, F., Winther, D., Martin, M., Aapro, M. S. and von Minckwitz, G. 2009. Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs. 13, 49-59.?
Berria, R., Glass, L., Mahankali, A., Miyazaki, Y., Monroy, A., De Filippis, E., Cusi, K., Cersosimo, E., Defronzo, R. A. and Gastaldelli, A. 2007. Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus. Clin. Pharmacol. Ther. 82, 275-281.?
Blanquicett, C., Roman, J. and Hart, C. M. 2008. Thiazolidinediones as anti-cancer agents. Cancer Ther. 6, 25-34.?
Bozdag, S. C., Yuksel, M. K. and Demirer, T. 2018. Adult stem cells and medicine. Adv. Exp. Med. Biol. 1079, 17-36.?
Buchbinder, E. I. and Desai, A. 2016. CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. Am. J. Clin. Oncol. 39, 98-106.?
Burdick, J. A. and Vunjak-Novakovic, G. 2009. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng. Part A. 15, 205-219.?
Chabner, B. A. and Roberts, T. G. Jr. 2005. Timeline: Chemotherapy and the war on cancer. Nat. Rev. Cancer 5, 65-72.?
Chen, Y., Yang, S., Liu, L., Yang, X., Duan, Y., Zhang, S. and Han, J. 2023. A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate. Eur. J. Pharmacol. 938, 175428.?
DeBerardinis, R. J. 2008. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet. Med. 10, 767-777.?
DeFronzo, R. A., Inzucchi, S., Abdul-Ghani, M. and Nissen, S. E. 2019. Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes. Diab. Vasc. Dis. Res. 16, 133-143.?
Del Monte, U. 2009. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell Cycle 8, 505-506.?
DePeaux, K. and Delgoffe, G. M. 2021. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785-797.?
Dillekas, H., Rogers, M. S. and Straume, O. 2019. Are 90% of deaths from cancer caused by metastases? Cancer Med. 8, 5574-5576.?
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D. and Horwitz, E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.?
Dulak, J., Szade, K., Szade, A., Nowak, W. and Jozkowicz, A. 2015. Adult stem cells: hopes and hypes of regenerative medicine. Acta. Biochim. Pol. 62, 329-337.?
Eguizabal, C., Aran, B., Chuva de Sousa Lopes, S. M., Geens, M., Heindryckx, B., Panula, S., Popovic, M., Vassena, R. and Veiga, A. 2019. Two decades of embryonic stem cells: a historical overview. Hum. Reprod. Open 2019, hoy024.?
Elberg, G., Gimble, J. M. and Tsai, S. Y. 2000. Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. J. Biol. Chem. 275, 27815-27822.?
Fotia, C., Massa, A., Boriani, F., Baldini, N. and Granchi, D. 2015. Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells. Cytotechnology 67, 1073-1084.?
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. and Fares, Y. 2020. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target Ther. 12, 28.?
Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. and D'Incalci, M. 2019. Combination of PPARγ agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas. Clin. Cancer Res. 25, 7565-7575.?
Gallego-Jara, J., Lozano-Terol, G., Sola-Martinez, R. A., Canovas-Diaz, M. and de Diego Puente, T. 2020. Compressive review about Taxol®: history and future challenges. Molecules 25, 5986.?
Gregoire, F. M., Smas, C. M. and Sul, H. S. 1998. Understanding adipocyte differentiation. Physiol. Rev. 78, 783- 809.?
Gurusamy, N., Alsayari, A., Rajasingh, S. and Rajasingh, J. 2018. Adult Stem Cells for Regenerative Therapy. Prog. Mol. Biol. Transl. Sci. 160, 1-22.?
Hallakou, S., Doare, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M. F., Dugail, I., Morin, J., Auwerx, J. and Ferre, P. 1997. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46, 1393-1399.?
Hayes, J. D., Dinkova-Kostova, A. T. and Tew, K. D. 2020. Oxidative stress in cancer. Cancer Cell 38, 167-197.?
Hishida, T., Nishizuka, M., Osada, S. and Imagawa, M. 2009. The role of C/EBPdelta in the early stages of adipogenesis. Biochimie 91, 654-657.?
Hung, S. H., Yeh, C. H., Huang, H. T., Wu, P., Ho, M. L., Chen, C. H., Wang, C., Chao, D. and Wang, G. J. 2008. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway. Life Sci. 82, 561-569.?
Ibrahim-Hashim, A. and Estrella, V. 2019. Acidosis and cancer: from mechanism to neutralization. Cancer Metastasis Rev. 38, 149-155.?
Jang, M., Kim, S. S. and Lee, J. 2013. Cancer cell metabolism: implications for therapeutic targets. Exp. Mol. Med. 45, e45.?
Jeon, B. G., Jang, S. J., Park, J. S., Subbarao, R. B., Jeong, G. J., Park, B. W. and Rho, G. J. 2015. Differentiation potential of mesenchymal stem cells isolated from human dental tissues into non-mesodermal lineage. Anim. Cells Syst. 19, 321-331.?
Jeon, B. G., Kumar, B. M., Kang, E. J., Ock, S. A., Lee, S. L., Kwack, D. O., Byun, J. H., Park, B. W. and Rho, G. J. 2011. Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins. Cell Tissue Res. 345, 149-161.?
Kapetanou, M., Chondrogianni, N., Petrakis, S., Koliakos, G. and Gonos, E. S. 2017. Proteasome activation enhances stemness and lifespan of human mesenchymal stem cells. Free Radic. Biol. Med. 103, 226-235.?
Kim, D. Y., Moon, S. H., Han, J. H., Kim, M. J., Oh, S. J., Bharti, D., Lee, S. H., Park, J. K., Rho, G. J. and Jeon, B. G. 2020. Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells. Anim. Cells. Syst. (Seoul) 24, 329-340.?
Kim, H. I., Moon, S. H., Lee, W. C., Lee, H. J., Shivakumar, S. B., Lee, S. H., Park, B. W., Rho, G. J. and Jeon, B. G. 2018. Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines. Anim. Cells. Syst. (Seoul) 22, 178-188.?
Kole, L., Sarkar, M., Deb, A. and Giri, B. 2016. Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-γ pathway. Pharmacol. Rep. 68, 144-154.?
Kolios, G. and Moodley, Y. 2013. Introduction to stem cells and regenerative medicine. Respiration 85, 3-10.?
Krisher, R. L. and Prather, R. S. 2012. A role for the Warburg effect in preimplantation embryo development: metabolic modification to support rapid cell proliferation. Mol. Reprod. Dev. 79, 311-320.?
Kuhn, N. Z. and Tuan, R. S. 2010. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J. Cell Physiol. 222, 268-277.?
Lebovitz, H. E. 2019. Thiazolidinediones: the Forgotten Diabetes Medications. Curr. Diab. Rep. 27, 151.?
Leko, V. and Rosenberg, S. A. 2020. Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors. Cancer Cell 38, 454-472.?
Liberti, M. V. and Locasale, J. W. 2016. The warburg effect: How does it benefit cancer cells? Trends Biochem. Sci. 41, 211-218.?
Liu, J. J., Huang, R. W., Lin, D. J., Peng, J., Wu, X. Y., Lin, Q., Pan, X. L., Song, Y. Q., Zhang, M. H., Hou, M. and Chen, F. 2005. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. Ann. Oncol. 16, 455-459.?
Liu, L., Michowski, W., Kolodziejczyk, A. and Sicinski, P. 2019. The cell cycle in stem cell proliferation, pluripotency and differentiation. Nat. Cell Biol. 21, 1060-1067.?
Lutz, A. M., Willmann, J. K., Cochran, F. V., Ray, P. and Gambhir, S. S. 2008. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. PLoS Med. 15, e170.?
Lutzen, U., Zhao, Y., Lucht, K., Zuhayra, M., Marx, M., Cascorbi, I. and Culman, J. 2017. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism. Naunyn Schmiedeberg's Arch. Pharmacol. 390, 37-48.?
Mao, Z., Ke, Z., Gorbunova, V. and Seluanov, A. 2012. Replicatively senescent cells are arrested in G1 and G2 phases. Aging (Albany NY) 4, 431-435.?
Martinez-Reyes, I. and Chandel, N. S. 2021. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669-680.?
Medina, R. A. and Owen, G. I. 2002. Glucose transporters: expression, regulation and cancer. Biol. Res. 35, 9-26.?
Medves, S. and Demoulin, J. B. 2012. Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies. J. Cell Mol. Med. 16, 237-248.?
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J. and Siegel, R. 2022. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72, 409-436.?
Mineo, H., Oda, C., Chiji, H., Kawada, T., Shimizu, K. and Taira, T. 2007. Thiazolidinediones exhibit different effects on preadipocytes isolated from rat mesenteric fat tissue and cell line 3T3-L1 cells derived from mice. Cell Biol. Int. 31, 703-710.?
Morrison, J., Haldar, K., Kehoe, S. and Lawrie, T. A. 2012. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst. Rev. 2012, CD005343.?
Mota de Sa, P., Richard, A. J., Hang, H. and Stephens, J. M. 2017. Transcriptional regulation of adipogenesis. Compr. Physiol. 16, 635-674.?
Otte, A., Bucan, V., Reimers, K. and Hass, R. 2013. Mesenchymal stem cells maintain long-term in vitro stemness during explant culture. Tissue Eng. Part C Methods 19, 937-948.?
Panigrahy, D., Shen, L. Q., Kieran, M. W. and Kaipainen, A. 2003. Therapeutic potential of thiazolidinediones as anticancer agents. Expert Opin. Investig. Drugs 12, 1925-1937.?
Rippon, H. J. and Bishop, A. E. Embryonic stem cells. Cell Prolif. 37, 23-34.?
Roma-Rodrigues, C., Mendes, R., Baptista, P. V. and Fernandes, A. R. 2019. Targeting tumor microenvironment for cancer therapy. Int. J. Mol. Sci. 20, 840.?
Rosen, E. D., Walkey, C. J., Puigserver, P. and Spiegelman, B. M. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293-1307.?
Saiki, M., Hatta, Y., Yamazaki, T., Itoh, T., Enomoto, Y., Takeuchi, J., Sawada, U., Aizawa, S. and Horie, T. 2006. Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells. Int. J. Oncol. 29, 437-443.?
Sandouk, T., Reda, D. and Hofmann, C. 1993. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264, C1600-1608.?
Sarjeant, K. and Stephens, J. M. 2012. Adipogenesis. Cold Spring Harb. Perspect. Biol. 4, a008417.?
Shahzad, Q., Pu, L., Ahmed Wadood, A., Waqas, M., Xie, L., Shekhar Pareek, C., Xu, H., Liang, X. and Lu, Y. 2020. Proteomics analysis reveals that warburg effect along with modification in lipid metabolism improves in vitro embryo development under low oxygen. Int. J. Mol. Sci. 21, 1996.?
Shuai, Y., Liao, L., Su, X., Yu, Y., Shao, B., Jing, H., Zhang, X., Deng, Z. and Jin, Y. 2016. Melatonin treatment improves mesenchymal stem cells therapy by preserving stemness during long-term in vitro expansion. Theranostics 6, 1899-1917.?
Singhal, S., Vachani, A., Antin-Ozerkis, D., Kaiser, L. R. and Albelda, S. M. 2005. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin. Cancer Res. 11, 3974-386.?
Sottoriva, K. and Pajcini, K. V. 2021. Notch signaling in the bone marrow lymphopoietic niche. Front. Immunol. 12, 723055.?
Sun, J., Chen, Y. H., Liu, H. Y., Hondo, E., Zhou, Y. and Wu, Y. F. 2021. Thiazolidinedione: a privileged scaffold for the development of anticancer agents. Curr. Top Med. Chem. 21, 2529-2545.?
Szablewski, L. 2013. Expression of glucose transporters in cancers. Biochim. Biophys. Acta. 1835, 164-169.?
Teixeira, C., Sousa, A. P., Santos, I., Rocha, A. C., Alencastre, I., Pereira, A. C., Martins-Mendes, D., Barata, P., Baylina, P. and Fernandes, R. 2022. Enhanced 3T3-L1 differentiation into adipocytes by pioglitazone pharmacological activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ). Biology 11, 806.?
Uwaifo, G. I. and Ratner, R. E. 2005. Novel pharmacologic agents for type 2 diabetes. Endocrinol. Metab. Clin. North Am. 34, 155-197.?
Van Gansen, P. and Van Lerberghe, N. 1988. Potential and limitations of cultivated fibroblasts in the study of senescence in animals. A review on the murine skin fibroblasts system. Arch. Gerontol. Geriatr. 7, 31-74.?
Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.?
Vaupel, P., Schmidberger, H. and Mayer, A. 2019. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int. J. Radiat. Biol. 95, 912-919.?
Vellasamy, S., Sandrasaigaran, P., Vidyadaran, S., Abdullah, M., George, E. and Ramasamy, R. 2013. Mesenchymal stem cells of human placenta and umbilical cord suppress T-cell proliferation at G0 phase of cell cycle. Cell Biol. Int. 37, 250-256.?
Waller, C. F. 2018. Imatinib mesylate. Recent Results Cancer Res. 212, 1-27.?
Werner, C., Gensch, C., Poss, J., Haendeler, J., Bohm, M. and Laufs, U. 2011. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. Atherosclerosis 216, 23-34.?
Wood, L. D., Canto, M. I., Jaffee, E. M. and Simeone, D. M. 2022. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163, 386-402.?
Wu, H., Ding, Z., Hu, D., Sun, F., Dai, C., Xie, J. and Hu, X. 2012. Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death. J. Pathol. 227, 189-199.?
Yahya, E. B. and Alqadhi, A. M. 2021. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sci. 269, 119087.?
Yamakawa-Karakida, N., Sugita, K., Inukai, T., Goi, K., Nakamura, M., Uno, K., Sato, H., Kagami, K., Barker, N. and Nakazawa, S. 2002. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Cell Death Differ. 9, 513-526.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.